carbamazepine

GPTKB entity

Statements (62)
Predicate Object
gptkbp:instanceOf gptkb:drug
anticonvulsant
mood stabilizer
gptkbp:approvedInUS 1968
gptkbp:ATCCode gptkb:N03AF01
gptkbp:brand gptkb:Tegretol
gptkb:Carbatrol
gptkb:Epitol
gptkb:Equetro
gptkbp:CASNumber 298-46-4
gptkbp:category antimanic agent
tricyclic compound
gptkbp:chemicalFormula C15H12N2O
gptkbp:contraindication history of bone marrow depression
hypersensitivity to tricyclic compounds
gptkbp:discoveredBy gptkb:Walter_Schindler
gptkbp:discoveredIn 1953
gptkbp:eliminationHalfLife 12–17 hours
gptkbp:excretion urine
feces
gptkbp:hasBoxedWarning aplastic anemia and agranulocytosis
serious dermatologic reactions
https://www.w3.org/2000/01/rdf-schema#label carbamazepine
gptkbp:interactsWith gptkb:milk
gptkb:phenytoin
gptkb:warfarin
gptkb:valproic_acid
gptkb:erythromycin
oral contraceptives
gptkbp:legalStatus prescription only
gptkbp:mechanismOfAction blocks voltage-gated sodium channels
gptkbp:MeSH_ID D002220
gptkbp:metabolism liver
gptkbp:molecularWeight 236.27 g/mol
gptkbp:pregnancyCategory D (US)
gptkbp:PubChem_CID gptkb:CHEMBL108
2554
DB00564
CHEBI:3380
gptkbp:riskFactor HLA-B*1502 allele (increased risk of SJS in Asians)
gptkbp:routeOfAdministration oral
rectal
gptkbp:seriousAdverseEffect gptkb:Stevens-Johnson_syndrome
aplastic anemia
agranulocytosis
gptkbp:sideEffect nausea
vomiting
dizziness
rash
drowsiness
hyponatremia
gptkbp:UNII 33CM23913M
gptkbp:usedFor gptkb:trigeminal_neuralgia
bipolar disorder
epilepsy
peripheral neuropathy
gptkbp:bfsParent gptkb:CYP2C9
gptkb:Erythromycin
gptkb:CYP3_family
gptkb:CYP3A4
gptkb:Tegretol
gptkbp:bfsLayer 5